XML 23 R4.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF EARNINGS AND COMPREHENSIVE INCOME
$ in Thousands, € in Millions, ৳ in Millions, ¥ in Millions, £ in Millions, $ in Millions, $ in Millions, $ in Millions
 12 Months Ended
Dec. 29, 2024
USD ($)
$ / shares
Dec. 31, 2023
USD ($)
$ / shares
Profit or loss [abstract]    
Net sales (note 26) $ 3,270,590 $ 3,195,911
Cost of sales (note 16(c)) 2,266,911 2,315,857
Gross profit 1,003,679 880,054
Selling, general and administrative expenses (note 16(a)) 390,769 330,391
Gains (losses) arising from sale and leaseback transactions 0 (25,010)
Net insurance gains (note 16(f)) 0 (74,172)
Restructuring and acquisition-related (recoveries) costs (note 17) (5,329) 45,762
Impairment reversal 0 (40,770)
Operating income 618,239 643,853
Financial expenses, net (note 14(c)) 104,154 79,670
Earnings before income taxes 514,085 564,183
Income tax expense (note 18) 113,220 30,603
Net earnings 400,865 533,580
Other comprehensive (loss) income, net of related income taxes:    
Cash flow hedges (note 14(d)) (13,677) 3,805
Actuarial (loss) gain on employee benefit obligations (note 12(a)) (817) 1,717
Other comprehensive income (14,494) 5,522
Comprehensive income $ 386,371 $ 539,102
Earnings per share (note 19):    
Basic (in dollars per share) | $ / shares $ 2.46 $ 3.03
Diluted (in dollars per share) | $ / shares $ 2.46 $ 3.03